Webinar: De-Risk Therapeutic Antibody Drug Development Using Humanized FcRn Mice
De-Risk Antibody Drug Development using Humanized FcRn
Do you need reliable pharmacokinetic data (PK) to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? The humanized FcRn (Hu-FcRn) mouse model enables you to obtain clinically-relevant PK data related to drug half-life. This critically important PK data helps optimize the design of preclinical efficacy studies and to de-risk lead selection.
